JMI Hospital Requisite Manufacturing Limited (DSE: JHRML)
Bangladesh
· Delayed Price · Currency is BDT
55.60
-0.30 (-0.54%)
At close: Nov 14, 2024
JHRML Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 |
Revenue | 1,883 | 1,852 | 1,802 | 1,731 | 1,498 | 1,302 |
Revenue Growth (YoY) | 2.31% | 2.79% | 4.10% | 15.54% | 15.09% | - |
Cost of Revenue | 1,305 | 1,273 | 1,238 | 1,111 | 923 | 787.19 |
Gross Profit | 577.19 | 578.58 | 564.29 | 619.43 | 575.08 | 514.43 |
Selling, General & Admin | 154.93 | 145.16 | 134.28 | 127.45 | 117.72 | 100.72 |
Other Operating Expenses | 0.72 | 0.59 | 0.44 | 0.39 | 0.72 | - |
Operating Expenses | 155.65 | 145.75 | 134.73 | 127.85 | 118.44 | 100.72 |
Operating Income | 421.53 | 432.82 | 429.57 | 491.58 | 456.64 | 413.71 |
Interest Expense | -56.9 | -73.34 | -99.28 | -112.18 | -79.2 | -134.38 |
Interest & Investment Income | 10.73 | 14.21 | 7.02 | 0.94 | 1.14 | 1.32 |
Currency Exchange Gain (Loss) | - | - | - | -0.14 | -1.14 | -0.36 |
Other Non Operating Income (Expenses) | 2.99 | 3.3 | 3.3 | 2.41 | 2.04 | 3.88 |
EBT Excluding Unusual Items | 378.35 | 376.99 | 340.61 | 382.62 | 379.49 | 284.17 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.81 |
Pretax Income | 378.35 | 376.99 | 340.61 | 382.62 | 379.49 | 284.98 |
Income Tax Expense | 58.14 | 74.7 | 15.59 | 157.61 | 162.08 | 100.78 |
Net Income | 320.21 | 302.29 | 325.02 | 225 | 217.41 | 184.2 |
Net Income to Common | 320.21 | 302.29 | 325.02 | 225 | 217.41 | 184.2 |
Net Income Growth | 21.66% | -6.99% | 44.45% | 3.49% | 18.03% | - |
Shares Outstanding (Basic) | 125 | 125 | 100 | 90 | 90 | 83 |
Shares Outstanding (Diluted) | 125 | 125 | 100 | 90 | 90 | 83 |
Shares Change (YoY) | -0.82% | 25.34% | 11.07% | - | 8.15% | - |
EPS (Basic) | 2.56 | 2.41 | 3.25 | 2.50 | 2.42 | 2.21 |
EPS (Diluted) | 2.56 | 2.41 | 3.25 | 2.50 | 2.42 | 2.21 |
EPS Growth | 22.67% | -25.80% | 30.06% | 3.49% | 9.13% | - |
Free Cash Flow | 74.91 | 117.67 | 243.49 | 43.83 | 397.91 | 153.94 |
Free Cash Flow Per Share | 0.60 | 0.94 | 2.44 | 0.49 | 4.42 | 1.85 |
Dividend Per Share | 0.500 | 0.500 | 1.250 | - | 1.000 | 1.000 |
Dividend Growth | -60.00% | -60.00% | - | - | 0% | - |
Gross Margin | 30.66% | 31.24% | 31.32% | 35.79% | 38.39% | 39.52% |
Operating Margin | 22.39% | 23.37% | 23.84% | 28.40% | 30.48% | 31.78% |
Profit Margin | 17.01% | 16.32% | 18.04% | 13.00% | 14.51% | 14.15% |
Free Cash Flow Margin | 3.98% | 6.35% | 13.51% | 2.53% | 26.56% | 11.83% |
EBITDA | 568.38 | 586.11 | 593.17 | 673.16 | 574.3 | 453.14 |
EBITDA Margin | 30.19% | 31.65% | 32.92% | 38.89% | 38.34% | 34.81% |
D&A For EBITDA | 146.85 | 153.29 | 163.6 | 181.58 | 117.66 | 39.43 |
EBIT | 421.53 | 432.82 | 429.57 | 491.58 | 456.64 | 413.71 |
EBIT Margin | 22.39% | 23.37% | 23.84% | 28.40% | 30.48% | 31.78% |
Effective Tax Rate | 15.37% | 19.82% | 4.58% | 41.19% | 42.71% | 35.36% |
Advertising Expenses | - | 9.82 | 8.57 | 6.29 | 5.66 | 3.91 |
Source: S&P Capital IQ. Standard template. Financial Sources.